SeaSpine Announces Launch of Shoreline Anterior Cervical Standalone System

SeaSpine Holdings Corporation, a global developer of surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Shoreline Anterior Cervical Standalone (ACS) System, featuring TruProfile technology.
 
The Shoreline ACS System is designed to deliver maximum flexibility and modularity, offering zero- and low-profile plating options, including two, three and four hole variations, as well as 10 and 15 degree lordotic implants.  This selection provides surgeons the ability to intraoperatively address a wide range of anatomy, surgical situations or bone. In addition, TruProfile technology offers a low profile plate design at 1.6mm thickness, minimizing the profile on the anterior aspect of the spine and minimizing cephalad caudal encroachment of adjacent segments.
 
“Shoreline with TruProfile has met the challenge of combining ease of implant placement and plate fixation to allow for a more responsive approach to specific patient requirements,” stated Dr. James Bruffey, an orthopedic surgeon in San Diego, Calif.  
 
All Shoreline interbody implants feature proprietary NanoMetalene surface technology designed to provide a bone-friendly titanium surface while retaining the benefits associated with traditional PEEK devices, such as biocompatibility, a modulus of elasticity like bone, and excellent radiographic visibility for post-operative imaging. NanoMetalene describes a sub-micron layer of commercially pure titanium molecularly bonded to a PEEK implant using a proprietary, high-energy, low-temperature process. Unlike other titanium coating applications, this process maximizes the implant surface area that has titanium nanotopography.
 
“The modular design of Shoreline with TruProfile is intended to optimize operating room efficiency and maximize procedural flexibility, while NanoMetalene provides the latest in surface technology,” stated Keith Valentine, president and CEO of SeaSpine.  “In addition, we believe the hyperlordotic and large footprint offerings enable surgeons to assemble the best construct option to match patient anatomy.”
 
Carlsbad, Calif.-based SeaSpine designs, develops, and commercializes surgical solutions for treating spinal disorders. SeaSpine has a portfolio of orthobiologics and spinal implant solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine’s orthobiologics products consist of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal implant portfolio consists of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. SeaSpine currently markets its products in the United States and in over 30 countries worldwide.